https://www.selleckchem.com/pr....oducts/pf-3758309.ht
62; 95%CI, 0.17-2.26; =.486), heart failure (OR, 1.37; 95%CI, 0.39-4.77; =.622), hospitalization rate (OR, 0.85; 95%CI, 0.45-1.64; =.638), ICU admission (OR, 0.87; 95%CI, 0.30-2.50; =.798), or major acute cardiovascular events (OR, 1.06; 95%CI, 0.39-2.83; =.915). This neutral effect remained in a subgroup analysis of patients requiring hospitalization. Previous treatment with ACEI/ARB in patients with COVID-19 had no effect on mortality, heart failure, requirement for hospitalization, or ICU admission. Withdrawal of ACEI/ARB in patie
Like
Comment
Share
